Literature DB >> 3951708

Spontaneous remissions in spasmodic torticollis.

A Friedman, S Fahn.   

Abstract

We reviewed the frequency of spontaneous remissions in spasmodic torticollis (ST). One hundred sixteen patients with idiopathic ST (72 F, 44 M) were examined. The age at onset ranged from 9 to 69 (mean, 38.1 +/- 1.3). Twenty-one patients (18%) were Jewish. Eleven patients (9%) had a history of familial dystonia. Remissions longer than 1 year unrelated to treatment were observed in 14 patients (12%) (9 F, 5 M). They occurred in the first year of ST in 13 patients (93%) and in the eighth year in 1. Duration of remissions ranged from 1 to 20 years (mean, 6.5 +/- 1.6). Two patients had three remissions, and another had two. The mean age at the onset of ST in patients with remission was 26.4 +/- 3.3 (SEM) and ranged from 9 to 49. The age at the onset in the patients without remissions was 39.7 +/- 1.4, ranging from 10 to 69 (p less than 0.01). In the remission group, 3 patients were Jewish (21%); in the non-remission group, 18 (18%) were Jewish. There was a familial history in 1 case with remission (7%) and in 10 cases (10%) without remission. Spontaneous remissions in the course of ST seem to be more frequent in patients with early onset, and they occur usually during the first year.

Entities:  

Mesh:

Year:  1986        PMID: 3951708     DOI: 10.1212/wnl.36.3.398

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  13 in total

Review 1.  The genetics of primary torsion dystonia.

Authors:  U Müller; K G Kupke
Journal:  Hum Genet       Date:  1990-01       Impact factor: 4.132

2.  Clinical Characteristics and Response to Long-Term Botulinum Toxin Type A Therapy in Patients with Cervical Dystonia at a Neurology Clinic.

Authors:  Aysu Şen; Aysun Soysal; Baki Arpaci
Journal:  Noro Psikiyatr Ars       Date:  2014-12-01       Impact factor: 1.339

3.  Sex prevalence of focal dystonias.

Authors:  V L Soland; K P Bhatia; C D Marsden
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-02       Impact factor: 10.154

4.  Costs of treating dystonias and hemifacial spasm with botulinum toxin A.

Authors:  R C Dodel; A Kirchner; R Koehne-Volland; G Künig; A Ceballos-Baumann; M Naumann; A Brashear; H P Richter; T D Szucs; W H Oertel
Journal:  Pharmacoeconomics       Date:  1997-12       Impact factor: 4.981

Review 5.  Cervical dystonia pathophysiology and treatment options.

Authors:  M Velickovic; R Benabou; M F Brin
Journal:  Drugs       Date:  2001       Impact factor: 9.546

6.  Genetic evidence for an association of the TOR1A locus with segmental/focal dystonia.

Authors:  Nutan Sharma; Ramon A Franco; John K Kuster; Adele A Mitchell; Tania Fuchs; Rachel Saunders-Pullman; Deborah Raymond; Mitchell F Brin; Andrew Blitzer; Susan B Bressman; Laurie J Ozelius
Journal:  Mov Disord       Date:  2010-10-15       Impact factor: 10.338

7.  Search for a founder mutation in idiopathic focal dystonia from Northern Germany.

Authors:  C Klein; L J Ozelius; J Hagenah; X O Breakefield; N J Risch; P Vieregge
Journal:  Am J Hum Genet       Date:  1998-12       Impact factor: 11.025

8.  EMG biofeedback treatment of torticollis: a controlled outcome study.

Authors:  M Jahanshahi; G Sartory; C D Marsden
Journal:  Biofeedback Self Regul       Date:  1991-12

Review 9.  Psychogenic movement disorders: diagnosis and management.

Authors:  Madhavi Thomas; Joseph Jankovic
Journal:  CNS Drugs       Date:  2004       Impact factor: 5.749

10.  Neural correlates of abnormal sensory discrimination in laryngeal dystonia.

Authors:  Pichet Termsarasab; Ritesh A Ramdhani; Giovanni Battistella; Estee Rubien-Thomas; Melissa Choy; Ian M Farwell; Miodrag Velickovic; Andrew Blitzer; Steven J Frucht; Richard B Reilly; Michael Hutchinson; Laurie J Ozelius; Kristina Simonyan
Journal:  Neuroimage Clin       Date:  2015-10-30       Impact factor: 4.881

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.